 |
etrolizumab |
|---|---|
| Trade Name | |
| Orphan Indication | Ulcerative colitis |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-22 00:00:00 |
| Sponsor | Genentech, Inc.;1 Dna Way;South San Francisco, California, 94080 |
Related Access Program
| |
etrolizumab |
|---|---|
| Trade Name | |
| Orphan Indication | Ulcerative colitis |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-22 00:00:00 |
| Sponsor | Genentech, Inc.;1 Dna Way;South San Francisco, California, 94080 |